Estados Unidos · Plataformas y datos · MarketBeat

Cybin Eyes Q4 Phase III Depression Data as Anxiety Program Advances

Publicado por MarketBeat · Estados Unidos hace 1 h

Cybin (NASDAQ:HELP) outlined plans for two late-stage mental health programs, with top-line data from its Phase III APPROACH study of HLP003 in major depressive disorder expected…

Leer el artículo completo en MarketBeat Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.marketbeat.com)

Cybin Eyes Q4 Phase III Depression Data as Anxiety Program Advances

También te puede interesar

Westinghouse Air Brake Technologies: 3 Key Takeaways for Long-Term Investors

Kazia gains as Guggenheim is latest to initiate at Buy on lead asset

Medicare is a bargain. What America can’t afford is private health insurance.

Initial jobless claims highlight Thursday’s economic calendar

Goldman Sachs, JPMorgan and Morgan Stanley are dominating the AI stock boom. Here's their edge

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Cybin Eyes Q4 Phase III Depression Data as Anxiety Program Advances

Compartir

También te puede interesar

Westinghouse Air Brake Technologies: 3 Key Takeaways for Long-Term Investors

Kazia gains as Guggenheim is latest to initiate at Buy on lead asset

Medicare is a bargain. What America can’t afford is private health insurance.

Initial jobless claims highlight Thursday’s economic calendar

Goldman Sachs, JPMorgan and Morgan Stanley are dominating the AI stock boom. Here's their edge

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030